The American Association of Critical-Care Nurses (AACN) invites nurses and other healthcare professionals who care for high acuity and critically ill patients and their families to its 2015 National Teaching Institute & Critical Care Exposition (NTI) in San Diego, May 18-21, with preconferences May 17.
The premier annual event for critical care nursing, NTI offers hundreds of sessions to improve clinical practice, patient outcomes and the hospital's bottom line with a comprehensive program that incorporates the best evidence-based education.
In addition to emerging trends in patient care, NTI sessions will focus on best practices, advances in medical technology and many other issues facing those in the healthcare profession.
Most of the 300-plus sessions will take place at the San Diego Convention Center, with the nearby Manchester Grand Hyatt and Marriott Marquis & Marina hotels also hosting official events.
The Advanced Practice Institute, integrated into NTI, has more than 60 sessions with content specifically developed for advanced practice nurses, including preconferences, clinical sessions, leadership role development, pharmacology and mastery sessions.
NTI, the world's largest conference for nurses who care for high acuity and critically ill patients, includes the Critical Care Exposition, the largest and most comprehensive trade show expressly for acute and critical care nurses. There will be more than 350 exhibits spread over 200,000 square feet that encompass cutting-edge healthcare equipment, devices, supplies and career opportunities.
Participants can earn up to 35 hours of continuing nursing education (CNE) during NTI. CNE hours — calculated on a 60-minute contact hour — are determined by the number of sessions a participant attends.
As an added value, attendees will receive online access to approximately 200 recorded sessions from NTI 2015, previous conferences and certification review courses. These materials will extend the on-site learning offered during the conference and be available through July 31.
Multiomic signatures identified for rapid detection and treatment of high-risk T-ALL